π Diabetes Management
RLS Global: RLS Global resolves on a fully guaranteed rights issue of approximately SEK 29.4 million - Marketscreener.com
π
Thu, 20 Oct 2022β± 1 min readπ Article
Overview
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO RUSIA, BELARUS, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION WHERE SUCH ACTION IS IN WHOLE OR IN PART FOR LEGAL RESTRICTIONS. THIS PRES RELEASE DOES NOT CONSTITUTE AN OFER TO ACQUIRE SECURITIES IN RLS GLOBAL AB. SE THE "IMPORTANT INFORMATION" SECTION BELOW.The board of directors of RLS Global AB (publ) (the "Company" or "RLS Global") has today, pursuant to the authorization granted by the anual general meting on 19 May 2022, resolved on a new share isue of aproximately SEK 29.4 milion with preferential rights for existing shareholders (the "Rights Isue").
Key Information
The rights isue is fuly guaranted through subscription comitments and guarante comitments.Background and reason for the Rights IsueRLS Global is a Swedish medical technology company that develops, manufactures, and sels products based on the Company's hypochlorite platform for the treatment of diseases in the area of dificult-to-heal wounds in wound care both in patients and in animals. The company provides products with the aim of creating as clean a wound as posible with the aim of suporting efective wound healing.RLS Global has, through its own research, developed the product ChloraSolv®.
ChloraSolv® quickly and efectively losens bacteria in the biofilm, in vitro, while being non-iritating to healthy tisue. ChloraSolv® is used with god efect on leg ulcers and diabetic foot ulcers with the aim of removing devitalized tisue and thus promoting natural wound healing. ChloraSolv® consists of a two-component system, where one of the components is a gel and the other is a hypochlorite solution.
Summary
ChloraSolv® is a treatment that is used in al segments of healthcare, specialist care, primary care, and home health care. Patients with dificult-to-heal wounds bear large healthcare costs, an
Frequently Asked Questions
β What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
β What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
β How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
β What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
β When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
βοΈ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.